Cargando…
p33(ING1b) methylation in fecal DNA as a molecular screening tool for colorectal cancer and precancerous lesions
The present study aimed to investigate the feasibility of detecting p33 inhibitor of growth 1b (p33(ING1b)) gene methylation in fecal DNA as a screening method for colorectal carcinoma (CRC) and precancerous lesions. The methylation of p33(ING1b) was analyzed in fecal samples from 61 patients with C...
Autores principales: | HE, CHUN-GANG, HUANG, QIN-YUAN, CHEN, LI-SHENG, LING, ZHI-AN, WU, HONG-GEN, DENG, HONG-QIANG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997675/ https://www.ncbi.nlm.nih.gov/pubmed/24765192 http://dx.doi.org/10.3892/ol.2014.1923 |
Ejemplares similares
-
Precancerous Lesions in Colorectal Cancer
por: Sandouk, Fayez, et al.
Publicado: (2013) -
A New Method for the Detection of Colorectal Cancer and the Precancerous Lesions: Occult Blood Testing Combination with Promoter Methylation in the Fecal Sample
por: Wang, Dan-Yang, et al.
Publicado: (2021) -
A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions
por: Li, Yuan, et al.
Publicado: (2023) -
Tissue vs. Fecal-Derived Bacterial Dysbiosis in Precancerous Colorectal Lesions: A Systematic Review
por: Valciukiene, Jurate, et al.
Publicado: (2023) -
Expression of P33(ING1b) Protein in Colorectal Cancer
por: Fallahnezhad, Somayeh, et al.
Publicado: (2016)